About PuriCore

PuriCore (AIM:PURI) is an emerging biopharmaceutical company passionately committed to leveraging its proprietary technologies to protect and improve the health of adults and children. In 2016, the Company began development of small molecule, immunomodulatory drug therapies in inflammatory diseases, with potential application in dermatology, ophthalmology and rare diseases. The Company is listed on the London Stock Exchange and is headquartered in Malvern, Pennsylvania. PuriCore utilizes differe

Company Highlights
Year Founded

1997

icon-altEmployees

51

Location (HQ)

USA

icon-altMoM Headcount Growth

-1.92%

icon-altYoY Headcount Growth

-3.77%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Medical

Biotechnology

Biotechnology Research

E-Commerce